Tehran University of Medical Sciences

Science Communicator Platform

Share By
Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19 Publisher



Kolahchi Z1 ; Sohrabi H1 ; Ekrami Nasab S1 ; Jelodari Mamaghani H1 ; Keyfari Alamdari M1 ; Rezaei N2, 3, 4
Authors

Source: Allergy# Asthma and Clinical Immunology Published:2021


Abstract

Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and management options to reduce the burden of the COVID-19 disease are under investigation. IVIG therapy is used as an effective treatment for immunodeficient patients and patients with inflammatory or autoimmune conditions. The therapeutic effect of IVIG in COVID-19 patients has been investigated. But, the results are controversial and some studies reported no benefit of IVIG therapy. More clinical trials on the effect of IVIG therapy in COVID-19 patients should be performed to establish a certain conclusion about IVIG effectiveness. © 2021, The Author(s).
Related Docs
View other Related Docs
1. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
2. The Outcome of Using Intravenous Immunoglobulin (Ivig) in Critically Ill Covid-19 Patients’: A Retrospective, Multi-Centric Cohort Study, European Journal of Medical Research (2022)
3. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Zeinab Aryanian (1)
Other Related Docs
4. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
5. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
6. Artesunate, Imatinib, and Infliximab in Covid-19: A Rapid Review and Meta-Analysis of Current Evidence, Immunity# Inflammation and Disease (2022)
7. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
8. Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in Covid-19 Patients: A Systematic Review of Current Evidence, Anti-Infective Agents (2024)
9. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
10. A Systematic Review on Efficacy, Safety and Treatment Durability of Intravenous Immunoglobulin in Autoimmune Bullous Dermatoses: Special Focus on Indication and Combination Therapy, Experimental Dermatology (2023)
11. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
12. Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of Covid-19 Outpatients: A Cross-Sectional Study, Iranian Journal of Science and Technology# Transaction A: Science (2022)
13. Intravenous Immunoglobulin Therapy in Myocarditis, Iranian Journal of Allergy# Asthma and Immunology (2020)
14. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
15. Antiviral Therapy Inmanagement of Covid-19: A Systematic Review on Current Evidence, Archives of Academic Emergency Medicine (2020)
16. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
17. Safety and Effectiveness Assessment of Intravenous Immunoglobulin in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis, Medical Journal of the Islamic Republic of Iran (2016)
18. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)
19. Pharmacotherapeutic Considerations in Solid Organ Transplant Patients With Covid-19, Expert Opinion on Pharmacotherapy (2020)
20. Antiretrovirals for Prophylaxis Against Covid-19: A Comprehensive Literature Review, Journal of Clinical Pharmacology (2021)